Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SCG2 is a Prognostic Biomarker Associated With Immune Infiltration and Macrophage Polarization in Colorectal Cancer. | Front Cell Dev Biol | 2021 | 35047505 | PubTator, text mining | PubMed |
| The Regulation of Growth in Developing, Homeostatic, and Regenerating Tetrapod Limbs: A Minireview. | Front Cell Dev Biol | 2021 | 35047496 | PubTator, text mining | PubMed |
| Derlin-1, as a Potential Early Predictive Biomarker for Nonresponse to Infliximab Treatment in Rheumatoid Arthritis, Is Related to Autophagy. | Front Immunol | 2021 | 35046954 | PubTator, text mining | PubMed |
| Case Report: An Unusual Course of Angiosarcoma After Lung Transplantation. | Front Immunol | 2021 | 35046948 | PubTator, text mining | PubMed |
| Characteristics of Clear Cell Papillary Renal Cell Carcinoma (ccpRCC). | Int J Mol Sci | 2021 | 35008576 | PubTator, text mining | PubMed |
| Collagen and Discoidin Domain Receptor 1 Partnership: A Multifaceted Role in the Regulation of Breast Carcinoma Cell Phenotype. | Front Cell Dev Biol | 2021 | 35004699 | PubTator, text mining | PubMed |
| HIF-1α Is a Rational Target for Future Ovarian Cancer Therapies. | Front Oncol | 2021 | 35004308 | PubTator, text mining | PubMed |
| Reflex testing in non-small cell lung carcinoma using DNA- and RNA-based next-generation sequencing-a single-center experience. | Transl Lung Cancer Res | 2021 | 35004252 | PubTator, text mining | PubMed |
| Transcriptional, Electrophysiological, and Metabolic Characterizations of hESC-Derived First and Second Heart Fields Demonstrate a Potential Role of TBX5 in Cardiomyocyte Maturation. | Front Cell Dev Biol | 2021 | 34988079 | PubTator, text mining | PubMed |
| P4HA1, a Prognostic Biomarker that Correlates With Immune Infiltrates in Lung Adenocarcinoma and Pan-Cancer. | Front Cell Dev Biol | 2021 | 34966739 | PubTator, text mining | PubMed |
| High Expression of CEMIP Correlates Poor Prognosis and the Tumur Microenvironment in Breast Cancer as a Promisingly Prognostic Biomarker. | Front Genet | 2021 | 34966410 | PubTator, text mining | PubMed |
| 29th Annual GP2A Medicinal Chemistry Conference. | Pharmaceuticals (Basel) | 2021 | 34959677 | PubTator, text mining | PubMed |
| The Extracellular Matrix in Soft Tissue Sarcomas: Pathobiology and Cellular Signalling. | Front Cell Dev Biol | 2021 | 34957097 | PubTator, text mining | PubMed |
| Mechanobiological Implications of Cancer Progression in Space. | Front Cell Dev Biol | 2021 | 34957091 | PubTator, text mining | PubMed |
| MiRNAs as Anti-Angiogenic Adjuvant Therapy in Cancer: Synopsis and Potential. | Front Oncol | 2021 | 34956857 | PubTator, text mining | PubMed |
| Discoidin Domain-Containing Receptor 2 Is Present in Human Atherosclerotic Plaques and Involved in the Expression and Activity of MMP-2. | Oxid Med Cell Longev | 2021 | 34956435 | PubTator, text mining | PubMed |
| Autism-Related Transcription Factors Underlying the Sex-Specific Effects of Prenatal Bisphenol A Exposure on Transcriptome-Interactome Profiles in the Offspring Prefrontal Cortex. | Int J Mol Sci | 2021 | 34947998 | PubTator, text mining | PubMed |
| MET Gene Dysregulation as a Promising Therapeutic Target in Lung Cancer-A Review. | J Pers Med | 2021 | 34945842 | PubTator, text mining | PubMed |
| Overcoming Therapy Resistance and Relapse in TNBC: Emerging Technologies to Target Breast Cancer-Associated Fibroblasts. | Biomedicines | 2021 | 34944738 | PubTator, text mining | PubMed |
| Selective Inhibition of HDAC Class I Sensitizes Leukemia and Neuroblastoma Cells to Anticancer Drugs. | Biomedicines | 2021 | 34944663 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=38